The current study seeks to test the feasibility of an alternative treatment for patients with
opioid use disorder who present to the emergency department seeking treatment or with opioid
withdrawal, which includes FDA approved long-acting medication for opioid misuse (SUBLOCADE)
and rapid transfer of care to outpatient substance abuse treatment.